DaVita Inc.

75.32+0.0800+0.11%Vol 82.77K1Y Perf -32.68%
Mar 24th, 2023 12:03 DELAYED
BID75.32 ASK75.40
Open74.84 Previous Close75.24
Pre-Market76.79 After-Market-
 1.55 2.06%  - -
Target Price
77.83 
Analyst Rating
Hold 3.17
Potential %
3.87 
Finscreener Ranking
+     37.65
Insiders Trans % 3/6/12 mo.
-/-33/-75 
Value Ranking
★★     45.28
Insiders Value % 3/6/12 mo.
75/67/-74 
Growth Ranking
★★     45.19
Insiders Shares Cnt. % 3/6/12 mo.
79/74/-60 
Income Ranking
 —    -
Price Range Ratio 52W %
16.87 
Earnings Rating
Strong Sell
Market Cap6.81B 
Earnings Date
4th May 2023
Alpha-0.00 Standard Deviation0.10
Beta1.19 

Today's Price Range

74.2875.44

52W Range

65.28124.81

5 Year PE Ratio Range

11.8089.60

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-1.99%
1 Month
-8.59%
3 Months
2.01%
6 Months
-12.83%
1 Year
-32.68%
3 Years
9.60%
5 Years
15.75%
10 Years
27.77%

TickerPriceChg.Chg.%
DVA75.320.08000.11
AAPL159.170.24390.15
GOOG105.79-0.4700-0.44
MSFT279.261.60000.58
XOM103.35-0.0600-0.06
WFC35.94-0.6700-1.83
JNJ152.161.03350.68
FB196.640.99000.51
GE92.250.66000.72
JPM124.40-2.4400-1.92
 
ProfitabilityValueIndustryS&P 500US Markets
27.10
12.60
18.70
10.90
7.54
RevenueValueIndustryS&P 500US Markets
8.69B
96.48
0.88
-3.80
Earnings HistoryEstimateReportedSurprise %
Q04 20220.881.1126.14
Q03 20221.651.45-12.12
Q02 20222.112.309.00
Q01 20221.851.61-12.97
Q04 20211.802.0212.22
Q03 20212.212.366.79
Q02 20212.142.6423.36
Q01 20211.802.0916.11
Earnings Per EndEstimateRevision %Trend
12/2022 QR0.88-57.69Negative
12/2022 FY6.31-17.41Negative
3/2023 QR1.22-36.79Negative
12/2023 FY6.46-33.54Negative
Next Report Date4th May 2023
Estimated EPS Next Report1.08
Estimates Count4
EPS Growth Next 5 Years %8.40
Volume Overview
Volume82.77K
Shares Outstanding90.40K
Shares Float58.09M
Trades Count2.66K
Dollar Volume6.19M
Avg. Volume719.45K
Avg. Weekly Volume741.11K
Avg. Monthly Volume755.10K
Avg. Quarterly Volume662.15K

DaVita Inc. (NYSE: DVA) stock closed at 75.24 per share at the end of the most recent trading day (a -1.97% change compared to the prior day closing price) with a volume of 506.11K shares and market capitalization of 6.81B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 67000 people. DaVita Inc. CEO is Javier J. Rodriguez.

The one-year performance of DaVita Inc. stock is -32.68%, while year-to-date (YTD) performance is 0.76%. DVA stock has a five-year performance of 15.75%. Its 52-week range is between 65.28 and 124.81, which gives DVA stock a 52-week price range ratio of 16.87%

DaVita Inc. currently has a PE ratio of 11.80, a price-to-book (PB) ratio of 13.71, a price-to-sale (PS) ratio of 0.82, a price to cashflow ratio of 4.60, a PEG ratio of 2.32, a ROA of 4.26%, a ROC of 7.31% and a ROE of 90.25%. The company’s profit margin is 7.54%, its EBITDA margin is 18.70%, and its revenue ttm is $8.69 Billion , which makes it $96.48 revenue per share.

Of the last four earnings reports from DaVita Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $1.08 for the next earnings report. DaVita Inc.’s next earnings report date is 04th May 2023.

The consensus rating of Wall Street analysts for DaVita Inc. is Hold (3.17), with a target price of $77.83, which is +3.87% compared to the current price. The earnings rating for DaVita Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DaVita Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DaVita Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 9.59, ATR14 : 2.22, CCI20 : -83.75, Chaikin Money Flow : 0.01, MACD : -1.33, Money Flow Index : 40.41, ROC : -4.58, RSI : 38.36, STOCH (14,3) : 22.36, STOCH RSI : 0.11, UO : 44.85, Williams %R : -77.64), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DaVita Inc. in the last 12-months were: Barbara J. Desoer (Option Excercise at a value of $474 968), Barbara J. Desoer (Sold 2 320 shares of value $226 010 ), Charles G. Berg (Option Excercise at a value of $712 418), Charles G. Berg (Sold 2 166 shares of value $167 622 ), James O. Hearty (Option Excercise at a value of $149 491), Javier J. Rodriguez (Option Excercise at a value of $5 232 441), John M. Nehra (Buy at a value of $355 675), Kathleen Alyce Waters (Option Excercise at a value of $2 740 860), Michael David Staffieri (Buy at a value of $1 554 000)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
5 (83.33 %)
5 (83.33 %)
5 (83.33 %)
Moderate Sell
1 (16.67 %)
1 (16.67 %)
1 (16.67 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
3.17
Hold
3.17
Hold
3.17

DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government ( primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

CEO: Javier J. Rodriguez

Telephone: +1 720 631-2100

Address: 2000 16th Street, Denver 80202, CO, US

Number of employees: 67 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

56%44%


News

Stocktwits